Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan 29;40(1):e20.
doi: 10.1017/S0266462323002738.

Introduction of hospital-based health technology assessment in China: experiences from seven pilot hospitals

Lanting Lyu  1   2 , Wenkai Shi  3 , Kristian Kidholm  4 , Fei Bai  5 , Xia Lin  5 , Jinlan Fu  1   2 , Tianqing Li  6   7 , Guoxun Li  8 , Li Luo  9 , Ting Wang  10 , Hai Yang  9
Affiliations

Introduction of hospital-based health technology assessment in China: experiences from seven pilot hospitals

Lanting Lyu et al. Int J Technol Assess Health Care. .

Abstract

Objectives: This study aimed to introduce a pilot program for hospital-based health technology assessment (HB-HTA) in China and present the participants' experiences based on seven case studies from seven tertiary hospitals.

Methods: One-year pilot projects were initiated at the beginning of 2018. Seven pilot hospitals were closely followed from the beginning until the completion of their pilot HTA project. Regular interviews were conducted with the hospital managers leading the HB-HTA projects and key members of the special HTA teams. Observations were made based on field trips and written HTA reports.

Results: Three pilot projects evaluated the use of medical consumables, three evaluated the use of surgical or medical interventions, and one evaluated an innovative management model for ventilators. Real-world data were collected from all the pilot projects to assist with the assessments. Most HB-HTA pilot projects achieved remarkable results such as improvements in economic efficiency; however, there were also obvious deficiencies such as the lack of a necessary cost-effectiveness analysis.

Conclusions: The results varied among the seven HB-HTA pilot projects. The HB-HTA pilot program was implemented to promote the use of HB-HTA in hospital decision making in China. At the same time, HB-HTA in China faces challenges. We have made some policy recommendations based on the findings of the pilot projects.

Keywords: China; case study; decision making; health reform; hospital management; hospital-based health technology assessment.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest for any of the authors.

Figures

Figure 1.
Figure 1.
Technical roadmap for hospital-based health technology assessment (HB-HTA) of peripheral nerve defect repair materials in the Sixth People’s Hospital of Shanghai.
Figure 2.
Figure 2.
Management flow chart of new technology and new project of Tianjin People’s Hospital for hospital-based health technology assessment (HB-HTA).
See this image and copyright information in PMC

References

    1. Xie F, Bowen JM, Sutherland SC, et al. Using health technology assessment to support evidence-based decision-making in Canada: An academic perspective. Expert Rev Pharm Out. 2011;11(5):513–521. - PubMed
    1. Zechmeister I, Schumacher I. The impact of health technology assessment reports on decision making in Austria. Int J Technol Assess Health Care. 2012;28(1):77–84. - PubMed
    1. Oortwijn W, Mathijssen J, Banta D. The role of health technology assessment on pharmaceutical reimbursement in selected middle-income countries. Health Policy. 2010;95(2–3):174–184. - PubMed
    1. Martelli N, Lelong A-S, Prognon P, Pineau J. Hospital-based health technology assessment for innovative medical devices in university hospitals and the role of hospital pharmacists: Learning from international experience. Int J Technol Assess Health Care. 2013;29(2):185–191. - PubMed
    1. Gagnon MP. Hospital-based health technology assessment: Developments to date. PharmacoEconomics. 2014;32(9):819–824. - PubMed